×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

À´×ÔÅ·ÖÞµÄÔ¼Çë | ELRIG DRUG DISCOVERY 2021

2021-10-20
|
»á¼ûÁ¿£º

DRUG-DISCOVERY.png

ELRIG Drug Discovery ÊÇÅ·ÖÞ×î´óµÄÉúÃü¿ÆÑ§ÐÐҵרҵÈËÊ¿¾Û»á£¬ÓÚ 2021 ÄêÇï¼¾»Ø¹é£¬ÒÔÇì×£ÐÐÒµµÄÁ¢ÒìºÍÆð¾¢ÒÔ¼°·ÖÏíеĿÆÑ§³É¼¨¡£½ñÄê¾Û»áµÄÖ÷ÌâÊÇ "After the Storm: Re-Connect, Re-Invent, Re-Imagine"¡£×ðÁú¿­Ê±Å·ÖÞÍŶӽ«²ÎÕ¹´Ë´Î¾Û»á£¬½Ó´ýݰÁÙ×ðÁú¿­Ê±Õ¹Ì¨½»Á÷»¥¶¯¡£

ELRIG¡¯s annual Drug Discovery meeting is Europe¡¯s largest meeting for life sciences industry professionals and return in the autumn of 2021, to celebrate the innovation and efforts of our industry and the scientific successes that we have shared throughout the period of the pandemic.

Welcome to Drug Discovery 2021

×ðÁú¿­Ê±Õ¹Î»ºÅ F15

ʱ¼ä |19-20 October 2021
ËùÔÚ |The Exhibition Centre, ACC, Liverpool

Agenda

¾Û»áÈÕ³Ì

Day 1 ¨C19th October 2021

New Approaches in Infection Biology
Diagnostic Testing and Biomarkers ¨C The New Normal?
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA
Alzheimer's Research UK

DAY 2 ¨C 20th October 2021

Screening Innovation to Enhance Drug Discovery
Innovative Strategies Supporting Drug Discovery
Disruptive Technologies
BPS Opportunities and Challenges of Drugging the Undruggable

Medicilon Service Scope

ЧÀ͹æÄ£

Medicilon Service Scope.png

×ðÁú¿­Ê±£¨¹ÉƱ´úÂ룺688202£©½¨ÉèÓÚ2004Ä꣬×ܲ¿Î»ÓÚÉϺ££¬ÖÂÁ¦ÓÚΪȫÇòÖÆÒ©ÆóÒµ¡¢Ñо¿»ú¹¹¼°¿ÆÑÐÊÂÇéÕßÌṩȫ·½Î»µÄÁÙ´²Ç°ÐÂÒ©Ñо¿Ð§ÀÍ¡£×ðÁú¿­Ê±µÄһվʽ×ÛºÏЧÀÍÒÔÇ¿ÓÐÁ¦µÄÏîÄ¿ÖÎÀíºÍ¸ü¸ßЧ¡¢¸ßÐԼ۱ȵÄÑз¢Ð§ÀÍÖúÁ¦¿Í»§¼ÓËÙÐÂÒ©Ñз¢Àú³Ì£¬Ð§Àͺ­¸ÇÒ½Ò©ÁÙ´²Ç°ÐÂÒ©Ñо¿µÄÈ«Àú³Ì£¬°üÀ¨Ò©Îï·¢Ã÷¡¢Ò©Ñ§Ñо¿¼°ÁÙ´²Ç°Ñо¿¡£

From its inception in 2004, Shanghai MedicilonInc. (STAR Market stock code: 688202.SH) has been committed to providingcomprehensive research and development (R&D) services to pharmaceuticalcompanies, research institutions, and any organizations working in thepreclinical space, with the primary objective of supporting and acceleratingpharmaceutical, biopharmaceutical R&D worldwide.

ÁªÏµ×ðÁú¿­Ê±£º
µç»°: +86 (21) 5859-1500£¨×Ü»ú£©
ÓªÒµ×ÉѯרÏߣº400-780-8018
Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿